NCT02521285 2025-10-23
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
University of Oxford
National Cancer Institute (NCI)
AstraZeneca